{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:02:37Z","timestamp":1789657357449,"version":"4.0.1"},"reference-count":172,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Frontiers in Neuroendocrinology"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.1006\/frne.1997.0158","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T18:33:54Z","timestamp":1034015634000},"page":"47-72","source":"Crossref","is-referenced-by-count":67,"title":["Growth Hormone-Releasing Peptides and Their Analogs"],"prefix":"10.1006","volume":"19","author":[{"given":"Franco","family":"Camanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Arvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/frne.1997.0158_FN970158RF1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1006\/bbrc.1995.1374","article-title":"The growth hormone secretagogue, L-692,429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors","volume":"208","author":"Adams","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1006\/frne.1997.0158_FN970158RF2","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1210\/endo.132.3.8095015","article-title":"Mechanisms of action of a second generation growth hormone-releasing peptide (Ala-His-dd","volume":"132","author":"Akman","year":"1993","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF3","first-page":"943","article-title":"Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects","volume":"79","author":"Aloi","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF4","first-page":"842","article-title":"The growth hormone (GH) response to GH-releasing peptide (His-dd","volume":"77","author":"Alster","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF5","first-page":"151","article-title":"Effects of Hexarelin (EP23905-MF6003) on circulating GH levels in acromegalic patients. (Highlights inMol Clin Endocrinol","volume":"9","author":"Arosio","year":"1994","journal-title":"Front Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF6","first-page":"1440","article-title":"Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects","volume":"79","author":"Arvat","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000126827","article-title":"Modulation of growth hormone-releasing activity of hexarelin in man","volume":"61","author":"Arvat","year":"1995","journal-title":"Neuroendocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0026-0495(97)90173-6","article-title":"Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of Hexarelin in man","volume":"46","author":"Arvat","year":"1997","journal-title":"Metabolism"},{"key":"10.1006\/frne.1997.0158_FN970158RF9","first-page":"3","article-title":"Supramaximal doses of GHRH or Hexarelin, a synthetic hexapeptide, enhance the low somatotrope responsiveness in aging","volume":"19","author":"Arvat","year":"1996","journal-title":"J Endocrinol Invest"},{"key":"10.1006\/frne.1997.0158_FN970158RF10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF03347854","article-title":"Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man","volume":"19","author":"Arvat","year":"1996","journal-title":"J Endocrinol Invest"},{"key":"10.1006\/frne.1997.0158_FN970158RF11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/eje.0.1360483","article-title":"Oestrogen replacement does not restore the reduced GH-releasing activity of hexarelin, a synthetic hexapeptide, in postmenopausal women","volume":"136","author":"Arvat","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF03346889","article-title":"Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man","volume":"20","author":"Arvat","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"10.1006\/frne.1997.0158_FN970158RF13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0196-9781(97)00016-8","article-title":"Effects of GHRP-2 and Hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol level in man. Comparison with the effects of GHRH, TRH, and hCRH","volume":"18","author":"Arvat","year":"1997","journal-title":"Peptides"},{"key":"10.1006\/frne.1997.0158_FN970158RF14","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1210\/endo-115-4-1432","article-title":"The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats","volume":"115","author":"Badger","year":"1984","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/joe.0.1290011","article-title":"Desensitization studies using perifused rat pituitary cells show that growth hormone-releasing hormone and His-dd","volume":"129","author":"Blake","year":"1991","journal-title":"J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF16","first-page":"1090","article-title":"Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, before and during puberty","volume":"80","author":"Bellone","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1530\/eje.0.1330425","article-title":"Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature","volume":"133","author":"Bellone","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF18","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1210\/endo-129-5-2592","article-title":"Sex differences in growth hormone (GH) secretion by rats administered GH-releasing hexapeptide","volume":"129","author":"Bercu","year":"1991","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF19","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/endo.130.5.1315249","article-title":"Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: Analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone","volume":"130","author":"Bercu","year":"1992","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-291X(05)81269-0","article-title":"Effect of substance P\/bombesin antagonists on the release of GH by GHRP and GHRH","volume":"5","author":"Bitar","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1006\/frne.1997.0158_FN970158RF21","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1210\/endo-114-5-1537","article-title":"On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone","volume":"114","author":"Bowers","year":"1984","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF22","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/jcem-70-4-975","article-title":"Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone","volume":"70","author":"Bowers","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF23","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/endo-128-4-2027","article-title":"On the action of the growth hormone-releasing hexapeptide, GHRP","volume":"128","author":"Bowers","year":"1991","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF24","first-page":"292","article-title":"The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration","volume":"74","author":"Bowers","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF25","series-title":"Growth Hormone II, Basic and Clinical Aspects","article-title":"Atypical growth hormone releasing peptides","author":"Bowers","year":"1993"},{"key":"10.1006\/frne.1997.0158_FN970158RF26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1515\/JPEM.1993.6.1.21","article-title":"GH releasing peptides: Structure and kinetics","volume":"6","author":"Bowers","year":"1993","journal-title":"J Pediatr Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF27","series-title":"Molecular and Clinical Advances in Pituitary Disorders","first-page":"153","article-title":"Novel GH-releasing peptides","author":"Bowers","year":"1993"},{"key":"10.1006\/frne.1997.0158_FN970158RF28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/BF03349808","article-title":"Exogenous growth hormone administration does not inhibit the growth hormone response to Hexarelin in normal men","volume":"18","author":"Cappa","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"10.1006\/frne.1997.0158_FN970158RF29","series-title":"Endocrinology and Metabolism Clinics of North America","first-page":"483","article-title":"Physiology of growth hormone secretion and action","author":"Casanueva","year":"1992"},{"key":"10.1006\/frne.1997.0158_FN970158RF30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0196-9781(94)00149-Z","article-title":"Hexarelin, a potent GHRP analogue: Interaction with GHRH and clonidine in young and aged dogs","volume":"16","author":"Cella","year":"1995","journal-title":"Peptides"},{"key":"10.1006\/frne.1997.0158_FN970158RF31","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1210\/endo.136.3.7867560","article-title":"Activity of a novel non peptidyl GH secretagogue, L-700,653, in swine","volume":"136","author":"Chang","year":"1995","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF32","unstructured":"Chang, C, H, Faidley, T, Rickes, L, McGuire, L, A, Nicolich, S, Murphy, T, Frazier, E, Chen, H, Smith, R, G, Hickey, J, Evidence that L-765,867 inhibits GH secretion when infused intravenously over a 12-hour period in swine, th, 1996, 486"},{"key":"10.1006\/frne.1997.0158_FN970158RF33","first-page":"4249","article-title":"Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects","volume":"81","author":"Chapman","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF34","first-page":"2874","article-title":"Enhancement of pulsatile growth hormone secretory by continous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults\u2014A clinical research center study","volume":"81","author":"Chapman","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF35","unstructured":"Chapman, I, M, Pescovitz, O, H, Treep, T, Murphy, G, Cerchio, K, Krupa, D, Gertz, B, Polvino, W, Skiles, E, H, Pezzoli, S, S, Thorner, M, O, Oral administration of the GHRP-mimetic MK-0677 stimulates the GH\/IGF-I axis in GH deficient adults, th, 1996, 769"},{"key":"10.1006\/frne.1997.0158_FN970158RF36","first-page":"127","article-title":"Fetal and neonatal somatotroph function","volume":"20","author":"Chatelain","year":"1994","journal-title":"Front Paediatr Neuroendocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF37","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1210\/endo-124-6-2791","article-title":"The synergistic effects of His-dd","volume":"124","author":"Cheng","year":"1989","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000183777","article-title":"A novel non-peptidyl growth hormone secretagogue","volume":"49","author":"Cheng","year":"1993","journal-title":"Horm Res"},{"key":"10.1006\/frne.1997.0158_FN970158RF39","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1210\/endo.132.6.8389289","article-title":"Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue","volume":"132","author":"Cheng","year":"1993","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF40","series-title":"Growth Hormone II, Basic and Clinical Aspects","first-page":"203","article-title":"Growth hormone releasing hexapeptide: Basic research and clinical application","author":"Chihara","year":"1993"},{"key":"10.1006\/frne.1997.0158_FN970158RF41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2265.1996.626446.x","article-title":"Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinemia patients","volume":"44","author":"Ciccarelli","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2826.1989.tb00112.x","article-title":"The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats","volume":"1","author":"Clark","year":"1989","journal-title":"J Neuroendocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF43","unstructured":"Clark, R, G, Mortenesen, D, L, Won, W, B, Ma, Y, H, Stanley, M, S, Somers, T, C, Fairhall, K, M, Thoams, G, B, Robinson, I, CAF, Novel GHRP analogs acutely activate the HPA axis and are diabetogenic in ZDF rats, th, 1996, 282"},{"key":"10.1006\/frne.1997.0158_FN970158RF44","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0028-3908(88)90062-7","article-title":"Binding of growth hormone-releasing hormone and enkephalin-derived growth hormone-releasing peptides to mu and delta opioid receptors in forbrain of rat","volume":"27","author":"Codd","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1006\/frne.1997.0158_FN970158RF45","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0028-3908(89)90129-9","article-title":"Binding of a growth hormone releasing hexapaptide to specific hypothalamic and pituitary binding sites","volume":"28","author":"Codd","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1006\/frne.1997.0158_FN970158RF46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000126826","article-title":"Mechanism of action of Hexarelin and GHRP-6: Analysis of the involvement of GHRH and somatostatin in the rat","volume":"61","author":"Conley","year":"1995","journal-title":"Neuroendocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF47","first-page":"2776","article-title":"Effects of 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men","volume":"81","author":"Copinschi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF48","first-page":"819","article-title":"Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: Evidence for a marked somatotroph secretory capability in obesity","volume":"76","author":"Cordido","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF49","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0026-0495(95)90187-6","article-title":"Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6 and pyridostigmine in normal and obese subjects","volume":"44","author":"Cordido","year":"1995","journal-title":"Metabolism"},{"key":"10.1006\/frne.1997.0158_FN970158RF50","first-page":"914","article-title":"Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression","volume":"81","author":"Cordido","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/edrv-14-1-20","article-title":"Human growth hormone and human aging","volume":"14","author":"Corpas","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1006\/frne.1997.0158_FN970158RF52","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1210\/jcem-72-6-1312","article-title":"Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: Partial response attenuation","volume":"72","author":"DeBell","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF53","series-title":"Growth Hormone Secretagogues","first-page":"85","article-title":"Growth hormone releasing peptides","author":"Deghenghi","year":"1993"},{"key":"10.1006\/frne.1997.0158_FN970158RF54","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0024-3205(94)00510-9","article-title":"GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats","volume":"54","author":"Deghenghi","year":"1994","journal-title":"Life Sci"},{"key":"10.1006\/frne.1997.0158_FN970158RF55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/JPEM.1995.8.4.311","article-title":"Small peptides as potent releasers of growth hormone","volume":"8","author":"Deghenghi","year":"1995","journal-title":"J Ped Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF56","unstructured":"Deghenghi, R, Boutignon, F, Luoni, F, Grilli, R, Guidi, M, Locatelli, V, Characterization of the activity of new growth hormone secretagogues in the infant rat, th, 1996, 280"},{"key":"10.1006\/frne.1997.0158_FN970158RF57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1358\/dof.1996.021.03.353289","article-title":"Benzolactam growth hormone secretagogues","volume":"21","author":"DeVita","year":"1996","journal-title":"Drugs Future"},{"key":"10.1006\/frne.1997.0158_FN970158RF58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000126825","article-title":"Central actions of peptide and non-peptide growth hormone secretagogues in the rat","volume":"61","author":"Dickson","year":"1995","journal-title":"Neuroendocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF59","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1677\/joe.0.1460519","article-title":"GH-deficient dw\/dw rats and lit\/lit mice show increased Fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6","volume":"146","author":"Dickson","year":"1995","journal-title":"J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF60","first-page":"255","article-title":"Role of glucocorticoids in the neuroregulation of growth hormone secretion","volume":"9","author":"Dieguez","year":"1996","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF61","first-page":"218","article-title":"Effect of a synthetic growth hormone releasing hexapeptide (BI 679) and growth hormone releasing factor (GRF) on serum growth hormone levels in barrows","volume":"59","author":"Doscher","year":"1984","journal-title":"J Anim Sci"},{"key":"10.1006\/frne.1997.0158_FN970158RF62","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2527\/1990.6851254x","article-title":"Effect of dose and frequency of administration of a potent analog of human growth hormone-releasing factor on hormone secretion in pigs","volume":"68","author":"Dubreuil","year":"1990","journal-title":"J Anim Sci"},{"key":"10.1006\/frne.1997.0158_FN970158RF63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1677\/joe.0.1210031","article-title":"Effects of hypothyroidism, tri-iodothyronine and glucocorticoids on growth hormone responses to growth hormone-releasing hormone and His-dd","volume":"121","author":"Edwards","year":"1989","journal-title":"J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF64","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1210\/endo.136.12.7588325","article-title":"In vitro characterization of four novel classes of growth hormone-releasing peptide","volume":"136","author":"Elias","year":"1995","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF65","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1677\/joe.0.1440555","article-title":"Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action","volume":"144","author":"Fairhall","year":"1995","journal-title":"J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF66","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1677\/joe.0.1450417","article-title":"Consistent GH responses to repeated injections of GH-releasing hexapeptide (GHRP-6) and the non-peptide GH secretagogue, L-692,585","volume":"145","author":"Fairhall","year":"1995","journal-title":"J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF67","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1056\/NEJM199603283341301","article-title":"A preliminary study of growth hormone in the treatment of dilated cardiomyopathy","volume":"334","author":"Fazio","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1006\/frne.1997.0158_FN970158RF68","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000126722","article-title":"Constitutive growth hormone secretion in sheep after hypothalamopituitary disconnection and the direct in vivo pituitary effect of growth hormone releasing peptide 6","volume":"60","author":"Fletcher","year":"1994","journal-title":"Neuroendocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF69","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1159\/000126883","article-title":"Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man","volume":"61","author":"Frieboes","year":"1995","journal-title":"Neuroendocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1210\/jcem-59-2-197","article-title":"Dose-response relationships for the effects of GH-releasing factor 1-44 NH2 in young adult men and women","volume":"59","author":"Gelato","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF71","first-page":"1393","article-title":"Growth hormone response in man to L-692,429, a novel non peptide mimic of growth hormone-releasing peptide-6","volume":"77","author":"Gertz","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF72","first-page":"745","article-title":"L-692,429, a non peptide growth hormone (GH) secretagogue reverses glucocorticoid suppression of GH secretion","volume":"79","author":"Gertz","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF73","series-title":"Growth Hormone and Somatic Growth","first-page":"103","article-title":"Neurotransmitter control of growth hormone secretion","author":"Ghigo","year":"1992"},{"key":"10.1006\/frne.1997.0158_FN970158RF74","series-title":"Growth Hormone and Somatomedins during Lifespan","first-page":"275","article-title":"Neural control of growth hormone secretion in aged humans","author":"Ghigo","year":"1993"},{"key":"10.1006\/frne.1997.0158_FN970158RF75","first-page":"693","article-title":"Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal and oral administration in man","volume":"78","author":"Ghigo","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF76","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF03347707","article-title":"Arginine enhances the growth hormone (GH)-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration","volume":"17","author":"Ghigo","year":"1994","journal-title":"J Endocrinol Invest"},{"key":"10.1006\/frne.1997.0158_FN970158RF77","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/eje.0.1310499","article-title":"Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging","volume":"131","author":"Ghigo","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF78","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1530\/eje.0.1350407","article-title":"Short term administration of intranasal or oral hexarelin, a synthetic hexapeptide, does not desensitize the GH responsiveness in human aging","volume":"135","author":"Ghigo","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF79","series-title":"Growth Hormone Secretagogues","first-page":"415","article-title":"Aging and GH-releasing peptides","author":"Ghigo","year":"1996"},{"key":"10.1006\/frne.1997.0158_FN970158RF80","unstructured":"Ghigo, E, Effects of GHRPs during lifespan in humans, th, 1996, 26"},{"key":"10.1006\/frne.1997.0158_FN970158RF81","first-page":"2439","article-title":"Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome","volume":"89","author":"Ghigo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1677\/joe.0.1460227","article-title":"Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess","volume":"146","author":"Giustina","year":"1995","journal-title":"J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF83","doi-asserted-by":"crossref","unstructured":"Giustina, A, Bonfani, C, Licini, M, Ragni, G, Stefana, B, Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1, th, 1996, 288","DOI":"10.1016\/S0167-0115(97)00017-7"},{"key":"10.1006\/frne.1997.0158_FN970158RF84","first-page":"939","article-title":"Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors","volume":"130","author":"Goth","year":"1992","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF85","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1530\/eje.0.1350678","article-title":"Selective refractoriness of somatotrope secretion to the inhibitory effect of hyperglycemia in obesity","volume":"135","author":"Grottoli","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF86","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1210\/endo.135.3.7915227","article-title":"Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep","volume":"135","author":"Guillame","year":"1994","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF87","first-page":"509","article-title":"Enhanced GH responses to combined administration of GHRP and GHRH in patients with acromegaly","volume":"78","author":"Hanew","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF88","first-page":"1378","article-title":"Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men","volume":"74","author":"Hartman","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1507\/endocrj1954.38.15","article-title":"Intranasal administration of His-dd","volume":"38","author":"Hayashi","year":"1991","journal-title":"Endocrinol Jpn"},{"key":"10.1006\/frne.1997.0158_FN970158RF90","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1210\/endo.135.3.8070352","article-title":"Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotropes by two mechanisms","volume":"135","author":"Herrington","year":"1994","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF91","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1210\/endo.134.2.8299565","article-title":"Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles","volume":"134","author":"Hickey","year":"1994","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF92","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1677\/joe.0.1480371","article-title":"Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585","volume":"148","author":"Hickey","year":"1996","journal-title":"J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF93","doi-asserted-by":"crossref","unstructured":"Hickey, G, J, Jacks, T, Schleim, K, Frazier, E, Chen, H, Krupa, D, Feeney, W, Narpunet, R, Patchett, A, Smith, R, G, Repeated administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-1 levels, th, 1996, 285","DOI":"10.1677\/joe.0.1520183"},{"key":"10.1006\/frne.1997.0158_FN970158RF94","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.273.5277.974","article-title":"A receptor in pituitary and hypothalamus that functions in growth hormone release","volume":"273","author":"Howard","year":"1996","journal-title":"Science"},{"key":"10.1006\/frne.1997.0158_FN970158RF95","first-page":"1202","article-title":"Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus","volume":"76","author":"Huhn","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF96","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1210\/jcem-69-1-212","article-title":"Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects","volume":"69","author":"Ilson","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF97","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF00191904","article-title":"Growth hormone releasing activity of hexarelin in humans: A dose\u2013response study","volume":"46","author":"Imbimbo","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1006\/frne.1997.0158_FN970158RF98","unstructured":"Ishii, S, Okada, K, Suzuki, N, Sugihara, H, Minami, S, Shibasaki, T, Wakabayashi, I, Effect of growth hormone-releasing peptide (KP-102) on food intake in rats, th, 1996, 282"},{"key":"10.1006\/frne.1997.0158_FN970158RF99","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1677\/joe.0.1430399","article-title":"Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-I, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles","volume":"143","author":"Jacks","year":"1994","journal-title":"J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF100","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1210\/endo.137.12.8940347","article-title":"MK-0677, a potent novel, orally-active growth hormone (GH) secretagogue: GH, insulin-like growth factor I, and other hormonal responses in beagles","volume":"137","author":"Jacks","year":"1996","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF101","first-page":"1641","article-title":"Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men","volume":"77","author":"Jaffe","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF102","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1530\/eje.0.1340716","article-title":"Desensitization from long-term intranasal treatment with Hexarelin does not interfere with the biological effects of this growth hormone-releasing peptide in short children","volume":"134","author":"Klinger","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/1043-2760(94)00204-H","article-title":"Growth hormone-releasing peptide and its analogues. Novel stimuli to growth hormone release","volume":"6","author":"Korbonits","year":"1995","journal-title":"Trends Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF104","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2265.1995.tb02045.x","article-title":"The effect of an opiate antagonist on the hormonal changes induced by hexarelin","volume":"43","author":"Korbonits","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF105","first-page":"123","article-title":"Analogues of growth hormone-releasing peptide (GHRP) do not affect the release of growth hormone-releasing hormone (GHRH) or somatostatin from the rat hypothalamus","volume":"148","author":"Korbonits","year":"1996","journal-title":"J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF106","first-page":"218","article-title":"Effect of a synthetic growth hormone releasing hexapeptide on serum growth hormone levels in steers","volume":"59","author":"Kraft","year":"1984","journal-title":"J Anim Sci"},{"key":"10.1006\/frne.1997.0158_FN970158RF107","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1530\/acta.0.1290424","article-title":"Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents","volume":"129","author":"Laron","year":"1993","journal-title":"Acta Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF108","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2265.1994.tb02589.x","article-title":"Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (Hexarelin)","volume":"41","author":"Laron","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF109","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2165\/00003495-199550040-00002","article-title":"Growth hormone secretagogues","volume":"50","author":"Laron","year":"1995","journal-title":"Drugs"},{"key":"10.1006\/frne.1997.0158_FN970158RF110","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2265.1995.tb02929.x","article-title":"Intranasal administration of the GHRP Hexarelin accelerates growth in short children","volume":"43","author":"Laron","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF111","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2265.1994.tb01831.x","article-title":"Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome","volume":"41","author":"Leal Cerro","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF112","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1530\/eje.0.1320712","article-title":"Growth hormone (GH) responses to the combined administration of GH-releasing peptide 6 in adults with GH deficiency","volume":"132","author":"Leal-Cerro","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF113","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/jme.0.0140135","article-title":"Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells","volume":"14","author":"Lei","year":"1995","journal-title":"J Mol Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF114","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1203\/00006450-199408000-00006","article-title":"Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat","volume":"36","author":"Locatelli","year":"1994","journal-title":"Ped Res"},{"key":"10.1006\/frne.1997.0158_FN970158RF115","first-page":"674","article-title":"The growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects","volume":"80","author":"Loche","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF116","first-page":"861","article-title":"The growth hormone response to Hexarelin in children: Reproducibility and effect of sex steroids","volume":"82","author":"Loche","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF117","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0024-3205(95)00087-9","article-title":"Intracerebroventricular growth-hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats","volume":"56","author":"Locke","year":"1995","journal-title":"Life Sci"},{"key":"10.1006\/frne.1997.0158_FN970158RF118","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0026-0495(95)90300-3","article-title":"Metabolic modulation of the growth-hormone-releasing activity of hexarelin in man","volume":"44","author":"Maccario","year":"1995","journal-title":"Metabolism"},{"key":"10.1006\/frne.1997.0158_FN970158RF119","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000126366","article-title":"Regulation of His-dd","volume":"57","author":"Mallo","year":"1993","journal-title":"Neuroendocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/jcem-73-2-314","article-title":"Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomologus macaque: Evidence for non-GHRH-mediated responses","volume":"73","author":"Malozowski","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF121","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2265.1995.tb02927.x","article-title":"Hexarelin induced growth hormone release is influenced by exogenous growth hormone","volume":"43","author":"Massoud","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF122","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1365-2265.1996.722543.x","article-title":"The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity","volume":"44","author":"Massoud","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF123","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/BF03350063","article-title":"Effect of the potentiation of cholinergic activity on the variability in individual GH response to GHRH","volume":"12","author":"Mazza","year":"1989","journal-title":"J Endocrinol Invest"},{"key":"10.1006\/frne.1997.0158_FN970158RF124","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1210\/endo-117-1-97","article-title":"Dose\u2013response characteristics of various peptides with growth hormone-releasing activity in the unanesthetized male rat","volume":"117","author":"McCormick","year":"1985","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF125","first-page":"11165","article-title":"Growth hormone secretagogues: Characterization, efficacy, and minimal bioactive conformation","volume":"92","author":"McDowell","year":"1995","journal-title":"Biochemistry"},{"key":"10.1006\/frne.1997.0158_FN970158RF126","first-page":"1681","article-title":"Growth hormone (GH) responses to GH-releasing peptide and to GH-releasing hormone in GH-deficient children","volume":"80","author":"Mericq","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF127","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2265.1995.tb01861.x","article-title":"Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood","volume":"42","author":"Micic","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF128","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1210\/endo-114-5-1531","article-title":"Conformational energy studies and in vitro and in vivo activity data on active GH releasing peptides","volume":"114","author":"Momany","year":"1984","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF129","first-page":"205","article-title":"Growth hormone-releasing peptide receptors in human brain and pituitary gland","volume":"10","author":"Muccioli","year":"1996","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1006\/frne.1997.0158_FN970158RF130","series-title":"Brain Messenger and the Pituitary","author":"Muller","year":"1989"},{"key":"10.1006\/frne.1997.0158_FN970158RF131","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1677\/joe.0.1380211","article-title":"Influence of endogenous cholinergic tone and alpha-adrenergic pathways on growth hormone responses to His-dd","volume":"138","author":"Muruais","year":"1993","journal-title":"J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF132","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.92.15.7001","article-title":"Design and biological activities of L-163,191 (MK-0677): A potent orally active growth hormone secretagogue","volume":"92","author":"Patchett","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/frne.1997.0158_FN970158RF133","first-page":"909","article-title":"Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentates the response to other GH-releasing stimuli","volume":"81","author":"Peino","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF134","first-page":"168","article-title":"Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man","volume":"76","author":"Penalva","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2265.1993.tb00977.x","article-title":"Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6","volume":"38","author":"Penalva","year":"1993","journal-title":"Clin Endocrinol (Oxford)"},{"key":"10.1006\/frne.1997.0158_FN970158RF136","first-page":"2987","article-title":"Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature","volume":"80","author":"Pihoker","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF137","doi-asserted-by":"crossref","unstructured":"Pihoker, C, Badger, T, M, Reynolds, G, A, Bowers, C, Y, Intranasal growth hormone (GH) releasing peptide-2 (GHRP-2) in children with GH deficiency: Growth effects and GH secretion: studies during treatment, th, 1996, 768","DOI":"10.1677\/joe.0.1550079"},{"key":"10.1006\/frne.1997.0158_FN970158RF138","first-page":"164","article-title":"Corticotropin-releasing hormone in humans","volume":"13","author":"Orth","year":"1992","journal-title":"Endocr Rev"},{"key":"10.1006\/frne.1997.0158_FN970158RF139","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1651-2227.1995.tb13790.x","article-title":"Plasma growth hormone response to growth hormone releasing hexapeptide (GHRP-6) in children with short stature","volume":"84","author":"Pombo","year":"1995","journal-title":"Acta Paediatr"},{"key":"10.1006\/frne.1997.0158_FN970158RF140","first-page":"3180","article-title":"Absence of growth hormone (GH) secretion after the administration of either GH releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection","volume":"80","author":"Pombo","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF141","first-page":"57","article-title":"Identification of a new G-protein-linked receptor for growth hormone secretagogues","volume":"10","author":"Pong","year":"1996","journal-title":"Mol Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF142","first-page":"456","article-title":"Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6","volume":"79","author":"Popovic","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF143","first-page":"942","volume":"80","author":"Popovic","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF144","first-page":"289","article-title":"Evaluation of pituitary GH reserve with GHRP-6","volume":"9","author":"Popovich","year":"1996","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF145","first-page":"1343","article-title":"Different growth hormone (GH) responses to GH-releasing peptide and GH-releasing hormone in hyperthyroidism","volume":"81","author":"Ramos-Dias","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF146","first-page":"1090","article-title":"Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: Interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide","volume":"78","author":"Renner","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF147","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0006-3223(91)90250-P","article-title":"Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders","volume":"29","author":"Rolla","year":"1991","journal-title":"Biol Psychiatr"},{"key":"10.1006\/frne.1997.0158_FN970158RF148","first-page":"1121","article-title":"Acute growth hormone (GH) response to GH-releasing hexapeptide in humans in independent of endogenous GH-releasing hormone","volume":"75","author":"Robinson","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF149","unstructured":"Robinson, I, CAF, Mechanism of action of GHRPs in vivo, th, 1996, 26"},{"key":"10.1006\/frne.1997.0158_FN970158RF150","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/eje.0.1320655","article-title":"Acquired growth hormone resistance","volume":"132","author":"Ross","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199007053230101","article-title":"Effects of human growth hormone in men over 60 years old","volume":"323","author":"Rudman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1006\/frne.1997.0158_FN970158RF152","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1210\/endo-116-3-952","article-title":"Parallel studies of His-dd","volume":"116","author":"Sartor","year":"1985","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF153","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/endo-117-4-1441","article-title":"Variables determining the growth hormone response of His-dd","volume":"117","author":"Sartor","year":"1985","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF154","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/BF03349794","article-title":"GH responsiveness to repeated GHRH or Hexarelin administration in normal adults","volume":"18","author":"Sartorio","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"10.1006\/frne.1997.0158_FN970158RF155","unstructured":"Scheim, K, D, Jacks, T, Cunningham, P, Feeney, W, Frazier, E, G, Niebauer, G, W, Zhang, D, Chen, H, Smith, R, G, Effect of MK-677 on growth hormone, IGF-I and cortisol in beagles before and after hypophysectomy, th, 1996, 285"},{"key":"10.1006\/frne.1997.0158_FN970158RF156","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0006-291X(91)91775-8","article-title":"Demonstration and characterization of the specific binding of growth hormone-releasing peptide to rat anterior pituitary and hypothalamic membranes","volume":"178","author":"Sethumadhavan","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1006\/frne.1997.0158_FN970158RF157","first-page":"1989","article-title":"Induction of c-fos mRNA in the arcuate nucleus of normal and mutant growth hormone-deficient mice by a synthetic non-peptydil growth hormone secretagogue","volume":"6","author":"Sirinathsinghji","year":"1995","journal-title":"Mol Neurosci"},{"key":"10.1006\/frne.1997.0158_FN970158RF158","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1126\/science.8503009","article-title":"A non-peptidyl GH secretagogue","volume":"260","author":"Smith","year":"1993","journal-title":"Science"},{"key":"10.1006\/frne.1997.0158_FN970158RF159","unstructured":"Tena-Sempere, M, Pinilla, L, Gonzalez, D, Aguilar, E, Nitric oxide (NO) blocked the GH response to growth hormone releasing hormone (GHRH), growth hormone releasing hexapeptide (GHRP-6),Nd, th, 1996, 287"},{"key":"10.1006\/frne.1997.0158_FN970158RF160","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1210\/endo.138.4.5065","article-title":"Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats","volume":"138","author":"Thomas","year":"1997","journal-title":"Endocrinology"},{"key":"10.1006\/frne.1997.0158_FN970158RF161","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1651-2227.1990.tb11628.x","article-title":"Growth hormone-releasing hormone and growthg hormone-releasing peptide as potential therapeutic modalities","volume":"367","author":"Thorner","year":"1990","journal-title":"Acta Paediatr Scand"},{"key":"10.1006\/frne.1997.0158_FN970158RF162","series-title":"Front in Paediatr Neuroendocrinol","first-page":"161","article-title":"Current status of therapy with growth hormone-releasing neuropeptides","author":"Thorner","year":"1994"},{"key":"10.1006\/frne.1997.0158_FN970158RF163","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0026-0495(95)90016-0","article-title":"Growth hormone (GH)-releasing effects of synthetic peptide GH-releasing peptide-2 and GH-releasing hormone (1-29NH2) in children with GH insufficiency and idiopathic short stature","volume":"44","author":"Tuilpakov","year":"1995","journal-title":"Metabolism"},{"key":"10.1006\/frne.1997.0158_FN970158RF164","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2265.1993.tb00348.x","article-title":"Influence of hyperthyroidism on growth hormone secretion","volume":"38","author":"Valcavi","year":"1993","journal-title":"Clin Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF165","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1210\/jcem-58-5-838","article-title":"Human pancreatic tumor growth hormone-releasing factor (hp GRF-40): Dose\u2013response relationship in normal man","volume":"58","author":"Vance","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/frne.1997.0158_FN970158RF166","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2265.1996.00805.x","article-title":"Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotropin-releasing hormone in critical illness","volume":"45","author":"Van der Berghe","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF167","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0024-3205(92)90457-Z","article-title":"Growth hormone-releasing peptide (GHRP) binding to porcine anterior pituitary and hypothalamic membranes","volume":"50","author":"Veeragavan","year":"1992","journal-title":"Life Sci"},{"key":"10.1006\/frne.1997.0158_FN970158RF168","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/0024-3205(91)90050-L","article-title":"Robust growth hormone (GH) secretion in aged female rats co-administered GH-releasing hexapeptide (GHRP-6) and GH-releasing hormone (GHRH)","volume":"49","author":"Walker","year":"1991","journal-title":"Life Sci"},{"key":"10.1006\/frne.1997.0158_FN970158RF169","series-title":"Growth hormone II, Basic and Clinical Aspects","first-page":"167","article-title":"Effects of growth hormone releasing peptides on stimulated growth hormone secretion in old rats","author":"Walker","year":"1993"},{"key":"10.1006\/frne.1997.0158_FN970158RF170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1677\/joe.0.140R009","article-title":"The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist","volume":"140","author":"Wu","year":"1994","journal-title":"J Endocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF171","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2826.1994.tb00571.x","article-title":"Effects in vitro of new growth hormone releasing peptide (GHRP-1) on growth hormone secretion from ovine pituitary cells in primary culture","volume":"6","author":"Wu","year":"1994","journal-title":"J Neuroendocrinol"},{"key":"10.1006\/frne.1997.0158_FN970158RF172","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000126958","article-title":"Effect of intravenous or intracerebroventricular injections of His-dd","volume":"63","author":"Yagi","year":"1996","journal-title":"Neuroendocrinology"}],"container-title":["Frontiers in Neuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091302297901588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091302297901588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T16:38:37Z","timestamp":1680626317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091302297901588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":172,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["S0091302297901588"],"URL":"https:\/\/doi.org\/10.1006\/frne.1997.0158","relation":{},"ISSN":["0091-3022"],"issn-type":[{"value":"0091-3022","type":"print"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}